These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21476867)

  • 1. Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors.
    Gray SJ; Foti SB; Schwartz JW; Bachaboina L; Taylor-Blake B; Coleman J; Ehlers MD; Zylka MJ; McCown TJ; Samulski RJ
    Hum Gene Ther; 2011 Sep; 22(9):1143-53. PubMed ID: 21476867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An adeno-associated virus-based intracellular sensor of pathological nuclear factor-κB activation for disease-inducible gene transfer.
    Chtarto A; Bockstael O; Gebara E; Vermoesen K; Melas C; Pythoud C; Levivier M; De Witte O; Luthi-Carter R; Clinkers R; Tenenbaum L
    PLoS One; 2013; 8(1):e53156. PubMed ID: 23301037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of an adeno-associated viral vector for efficient bicistronic expression of two genes in the central nervous system.
    Hutson TH; Kathe C; Menezes SC; Rooney MC; Bueler H; Moon LD
    Methods Mol Biol; 2014; 1162():189-207. PubMed ID: 24838969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.
    Chan KY; Jang MJ; Yoo BB; Greenbaum A; Ravi N; Wu WL; Sánchez-Guardado L; Lois C; Mazmanian SK; Deverman BE; Gradinaru V
    Nat Neurosci; 2017 Aug; 20(8):1172-1179. PubMed ID: 28671695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Infusion of AAV for Widespread Gene Delivery to the Nervous System.
    Gessler DJ; Tai PWL; Li J; Gao G
    Methods Mol Biol; 2019; 1950():143-163. PubMed ID: 30783972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered compact pan-neuronal promoter from Alphaherpesvirus LAP2 enhances target gene expression in the mouse brain and reduces tropism in the liver.
    Maturana CJ
    Gene Ther; 2024 May; 31(5-6):335-344. PubMed ID: 38012300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-Scale Production of Adeno-Associated Viral Vector Serotype-9 Carrying the Human Survival Motor Neuron Gene.
    Rashnonejad A; Chermahini GA; Li S; Ozkinay F; Gao G
    Mol Biotechnol; 2016 Jan; 58(1):30-6. PubMed ID: 26607476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ultra-compact promoter drives widespread neuronal expression in mouse and monkey brains.
    Wang J; Lin J; Chen Y; Liu J; Zheng Q; Deng M; Wang R; Zhang Y; Feng S; Xu Z; Ye W; Hu Y; Duan J; Lin Y; Dai J; Chen Y; Li Y; Luo T; Chen Q; Lu Z
    Cell Rep; 2023 Nov; 42(11):113348. PubMed ID: 37910509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates.
    Gray SJ; Matagne V; Bachaboina L; Yadav S; Ojeda SR; Samulski RJ
    Mol Ther; 2011 Jun; 19(6):1058-69. PubMed ID: 21487395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and systemic administration of AAV vectors with alphaherpesvirus latency-associated promoter 2 drives potent transgene expression in mouse liver, kidney, and skeletal muscle.
    Maturana CJ; Chan A; Verpeut JL; Engel EA
    J Virol Methods; 2023 Apr; 314():114688. PubMed ID: 36736702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of an enhancer from the rat tyrosine hydroxylase promoter that supports long-term, neuronal-specific expression from a neurofilament promoter, in a helper virus-free HSV-1 vector system.
    Gao Q; Sun M; Wang X; Geller AI
    Brain Res; 2007 Jan; 1130(1):1-16. PubMed ID: 17169349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong ubiquitous micro-promoters for recombinant adeno-associated viral vectors.
    Chai S; Wakefield L; Norgard M; Li B; Enicks D; Marks DL; Grompe M
    Mol Ther Methods Clin Dev; 2023 Jun; 29():504-512. PubMed ID: 37287749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient and Long-Term Transgene Expression in the CNS.
    Maturana CJ; Verpeut JL; Pisano TJ; Dhanerawala ZM; Esteves A; Enquist LW; Engel EA
    Mol Ther Methods Clin Dev; 2020 Jun; 17():843-857. PubMed ID: 32368565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional enhancer elements drive subclass-selective expression from mouse to primate neocortex.
    Mich JK; Graybuck LT; Hess EE; Mahoney JT; Kojima Y; Ding Y; Somasundaram S; Miller JA; Kalmbach BE; Radaelli C; Gore BB; Weed N; Omstead V; Bishaw Y; Shapovalova NV; Martinez RA; Fong O; Yao S; Mortrud M; Chong P; Loftus L; Bertagnolli D; Goldy J; Casper T; Dee N; Opitz-Araya X; Cetin A; Smith KA; Gwinn RP; Cobbs C; Ko AL; Ojemann JG; Keene CD; Silbergeld DL; Sunkin SM; Gradinaru V; Horwitz GD; Zeng H; Tasic B; Lein ES; Ting JT; Levi BP
    Cell Rep; 2021 Mar; 34(13):108754. PubMed ID: 33789096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered viral vectors for functional interrogation, deconvolution, and manipulation of neural circuits.
    Sun S; Schaffer DV
    Curr Opin Neurobiol; 2018 Jun; 50():163-170. PubMed ID: 29614429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent transgene expression in peripheral tissues one year post intravenous and intramuscular administration of AAV vectors containing the alphaherpesvirus latency-associated promoter 2.
    Maturana CJ; Engel EA
    Front Virol; 2024; 4():. PubMed ID: 38665693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma.
    Singh V; Pathak S; Kumar N; Jayandharan GR
    ACS Omega; 2024 Jul; 9(28):30945-30953. PubMed ID: 39035883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of the AAV-Compatible Hair Cell-Specific Small-Size Myo15 Promoter for Gene Therapy in the Inner Ear.
    Hu SW; Lv J; Wang Z; Tang H; Wang H; Wang F; Wang D; Zhang J; Zhang L; Cao Q; Chen Y; Gao Z; Han Y; Wang W; Li GL; Shu Y; Li H
    Research (Wash D C); 2024; 7():0341. PubMed ID: 38665848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of AAV vectors for transactivator-regulated enhanced gene expression within targeted neuronal populations.
    Kojima L; Seiriki K; Rokujo H; Nakazawa T; Kasai A; Hashimoto H
    iScience; 2024 Jun; 27(6):109878. PubMed ID: 38799556
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Carrell EM; Chen YH; Ranum PT; Coffin SL; Singh LN; Tecedor L; Keiser MS; Hudry E; Hyman BT; Davidson BL
    Mol Ther Nucleic Acids; 2023 Sep; 33():296-304. PubMed ID: 37547292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.